Kiniksa Pharmaceuticals International Plc (KNSA)
43.09
+0.51
(+1.20%)
USD |
NASDAQ |
Feb 06, 16:00
43.18
+0.09
(+0.20%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International SG&A Expense (TTM) : 180.03M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Marker Therapeutics, Inc. | 4.365M |
| NovoCure Ltd. | 445.94M |
| LivaNova Plc | 545.57M |
| ADMA Biologics, Inc. | 96.37M |
| Alterola Biotech, Inc. | -- |